Marathon Patent Group Inc. (NASDAQ:MARA) – Stock analysts at Roth Capital reduced their FY2016 EPS estimates for Marathon Patent Group in a research note issued to investors on Monday. Roth Capital analyst W. Gibson now anticipates that the firm will post earnings of ($0.40) per share for the year, down from their prior estimate of ($0.08). Roth Capital also issued estimates for Marathon Patent Group’s Q4 2016 earnings at ($0.18) EPS, Q1 2017 earnings at ($0.21) EPS, Q2 2017 earnings at ($0.19) EPS, Q3 2017 earnings at $0.36 EPS, Q4 2017 earnings at $0.23 EPS and FY2017 earnings at $0.20 EPS.
Separately, Zacks Investment Research lowered shares of Marathon Patent Group from a “hold” rating to a “sell” rating in a research note on Thursday, November 17th.
Shares of Marathon Patent Group (NASDAQ:MARA) opened at 1.82 on Wednesday. The stock’s market cap is $27.43 million. The company has a 50 day moving average price of $2.27 and a 200-day moving average price of $2.61. Marathon Patent Group has a one year low of $1.29 and a one year high of $3.44.
Marathon Patent Group (NASDAQ:MARA) last announced its quarterly earnings results on Monday, November 14th. The company reported ($0.42) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.25) by $0.17. Marathon Patent Group had a negative net margin of 14.15% and a negative return on equity of 10.36%.
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Eagle Global Advisors LLC acquired a new position in Marathon Patent Group during the third quarter worth $118,000. Vanguard Group Inc. raised its stake in Marathon Patent Group by 3.5% in the second quarter. Vanguard Group Inc. now owns 204,734 shares of the company’s stock valued at $561,000 after buying an additional 6,900 shares during the last quarter. Finally, Cambridge Investment Research Advisors Inc. raised its stake in Marathon Patent Group by 17.5% in the second quarter. Cambridge Investment Research Advisors Inc. now owns 848,449 shares of the company’s stock valued at $2,325,000 after buying an additional 126,565 shares during the last quarter. 9.09% of the stock is currently owned by institutional investors and hedge funds.
About Marathon Patent Group